Cardiometabolic

Cardiovascular Disease Is the Leading Cause of Morbidity and Mortality in Patients With Type 2 Diabetes

In 2018, approximately 1.5 million patients were diagnosed with diabetes.1 Patients with type 2 diabetes (T2D) face a variety of complications and comorbidities including cardiovascular (CV) disease, which is the most common cause of death among adults with T2D.1,2
Responsive image

2 out of 3 adults

with T2D will die from a CV event3

Learn more about a landmark outcome trial that demonstrated a medication's ability to reduce the risk of CV death in adults with T2D and CV disease when added to standard of care

Five targeted areas can help optimize care for adults with T2D at risk of dying of a CV event

Patient Education

Patient Education

Risk Assessment

Risk Assessment and Stratification

Care Transitions

Care Transitions

Collaborative-care-mgmt

Collaborative Care Management

Review

Evidence-based Guidelines on Managing CV Risk

Review the latest guidance from the American Diabetes Association® (ADA) on treatment advances like SGLT2 inhibitors